Search

Your search keyword '"Napoli, V."' showing total 318 results
Start Over Author "Napoli, V."
318 results on '"Napoli, V."'

1. Inflammatory activity of vulnerable plaques in asymptomatic, non-hemodynamically significant carotid artery stenoses: preliminary results of the carotid artery multi-modality imaging prognostic study

Author

Masini, G, primary, Gargani, L, additional, Baldini, M, additional, Aghakhanyan, G, additional, Volterrani, D, additional, Erba, P A, additional, Marciano, A, additional, Napoli, V, additional, Cosottini, M, additional, Lucchi, G, additional, D'angelo, G, additional, Morizzo, C, additional, Orlandi, G, additional, Palombo, C, additional, and De Caterina, R, additional

Published
2023
Full Text
View/download PDF

2. Imaging signs of vulnerability, neurological events and cognitive impairment in asymptomatic carotid artery stenosis: results from the Carotid Artery Multi-modality imaging Prognostic (CAMP) study

Author

Gargani, L, primary, Masini, G, additional, Baldini, M, additional, Napoli, V, additional, Orlandi, G, additional, Lucchi, G, additional, Totaro, P, additional, D'amelio, C, additional, Galeotti, G G, additional, Ghicopulos, I, additional, Nilsson, I, additional, Goncalves, I, additional, Palombo, C, additional, Cosottini, M, additional, and De Caterina, R, additional

Published
2023
Full Text
View/download PDF

4. Detecting the vulnerable carotid plaque: The Carotid Artery Multimodality imaging Prognostic study design

Author

Gargani, L, Baldini, M, Berchiolli, R, Bort, I, Casolo, G, Chiappino, D, Cosottini, M, D'Angelo, G, De Santis, M, Erba, P, Fabiani, I, Fabiani, P, Gabbriellini, I, Galeotti, G, Ghicopulos, I, Goncalves, I, Lapi, S, Masini, G, Morizzo, C, Napoli, V, Nilsson, J, Orlandi, G, Palombo, C, Pieraccini, F, Ricci, S, Siciliano, G, Slart, R, De Caterina, R, Gargani L., Baldini M., Berchiolli R., Bort I. R., Casolo G., Chiappino D., Cosottini M., D'Angelo G., De Santis M., Erba P., Fabiani I., Fabiani P., Gabbriellini I., Galeotti G. G., Ghicopulos I., Goncalves I., Lapi S., Masini G., Morizzo C., Napoli V., Nilsson J., Orlandi G., Palombo C., Pieraccini F., Ricci S., Siciliano G., Slart R. H. J. A., De Caterina R., Gargani, L, Baldini, M, Berchiolli, R, Bort, I, Casolo, G, Chiappino, D, Cosottini, M, D'Angelo, G, De Santis, M, Erba, P, Fabiani, I, Fabiani, P, Gabbriellini, I, Galeotti, G, Ghicopulos, I, Goncalves, I, Lapi, S, Masini, G, Morizzo, C, Napoli, V, Nilsson, J, Orlandi, G, Palombo, C, Pieraccini, F, Ricci, S, Siciliano, G, Slart, R, De Caterina, R, Gargani L., Baldini M., Berchiolli R., Bort I. R., Casolo G., Chiappino D., Cosottini M., D'Angelo G., De Santis M., Erba P., Fabiani I., Fabiani P., Gabbriellini I., Galeotti G. G., Ghicopulos I., Goncalves I., Lapi S., Masini G., Morizzo C., Napoli V., Nilsson J., Orlandi G., Palombo C., Pieraccini F., Ricci S., Siciliano G., Slart R. H. J. A., and De Caterina R.

Abstract

BackgroundCarotid artery disease is highly prevalent and a main cause of ischemic stroke and vascular dementia. There is a paucity of information on predictors of serious vascular events. Besides percentage diameter stenosis, international guidelines also recommend the evaluation of qualitative characteristics of carotid artery disease as a guide to treatment, but with no agreement on which qualitative features to assess. This inadequate knowledge leads to a poor ability to identify patients at risk, dispersion of medical resources, and unproven use of expensive and resource-consuming techniques, such as magnetic resonance imaging, positron emission tomography, and computed tomography.ObjectivesThe Carotid Artery Multimodality imaging Prognostic (CAMP) study will: prospectively determine the best predictors of silent and overt ischemic stroke and vascular dementia in patients with asymptomatic subcritical carotid artery disease by identifying the noninvasive diagnostic features of the 'vulnerable carotid plaque'; assess whether 'smart' use of low-cost diagnostic methods such as ultrasound-based evaluations may yield at least the same level of prospective information as more expensive techniques.Study designWe will compare the prognostic/predictive value of all proposed techniques with regard to silent or clinically manifest ischemic stroke and vascular dementia. The study will include ≥300 patients with asymptomatic, unilateral, intermediate degree (40-60% diameter) common or internal carotid artery stenosis detected at carotid ultrasound, with a 2-year follow-up. The study design has been registered on Clinicaltrial.gov on December 17, 2020 (ID number NCT04679727).

Published
2022

5. Neuroimaging evaluation of unilateral asymptomatic carotid plaque ulceration: preliminary results of the Carotid Artery Multimodality imaging Prognostic study

Author

Masini, G, primary, Gargani, L, additional, Napoli, V, additional, Cosottini, M, additional, Chiappino, D, additional, Orlandi, G, additional, D'Amelio, C, additional, Todaro, P, additional, Galeotti, G, additional, Bort, I R, additional, Baldini, M, additional, Aghakhanyan, G, additional, Erba, P, additional, Palombo, C, additional, and De Caterina, R, additional

Published
2022
Full Text
View/download PDF

6. 1355P Clinical trial enrollment among lung cancer patients: A real-world multicenter analysis

Author

Reale, M.L., primary, Capelletto, E., additional, Buttigliero, C., additional, Bordi, P., additional, Ricciardi, S., additional, Belluomini, L., additional, Garbo, E., additional, Leonetti, A., additional, Lombardi, A., additional, Dodi, A., additional, Napoli, V., additional, Casali, M., additional, Soregaroli, D., additional, Insolda, J., additional, Bironzo, P., additional, Tiseo, M., additional, Migliorino, M.R., additional, Pilotto, S., additional, Passiglia, F., additional, and Novello, S., additional

Published
2022
Full Text
View/download PDF

9. P59.20 Natural History of KRAS Mutant Non-Small-Cell Lung Cancer in the Immunotherapy Era: A Single-Centre Retrospective Study

Author

Bironzo, P., primary, Jacobs, F., additional, Cani, M., additional, Reale, M.L., additional, Tabbò, F., additional, Olmetto, E., additional, Capelletto, E., additional, Napoli, V., additional, Passiglia, F., additional, Listì, A., additional, Righi, L., additional, Di Maio, M., additional, Novello, S., additional, and Scagliotti, G., additional

Published
2021
Full Text
View/download PDF

10. HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects from the ICONA Italian Cohort of HIV-Infected Patients

Author

Malagnino, Vincenzo, Cerva, Carlotta, Cingolani, Antonella, Ceccherini-Silberstein, Francesca, Vergori, Alessandra, Cuomo, Gianluca, Perno, Carlo Federico, Puoti, Massimo, d'Arminio Monforte, Antonella, Cozzi-Lepri, Alessandro, Andreoni, Massimo, Sarmati, Loredana, d’Arminio Monforte (President), Icona Fundation Study Group. Board of Directors: A., Antinori (Vice-President), A., Andreoni, M., Castagna, A., Castelli, F., Cauda, R., Di Perri, G., Galli, M., Iardino, R., Ippolito, G., Lazzarin, A., Marchetti, G. C., Rezza, G., von Schloesser, F., d’Arminio Monforte, P. Viale. Scientific Secretary: A., Antinori, A., Ceccherinisilberstein, F., Cozzi-Lepri, A., Girardi, E., Gori, A., Lo Caputo, S., Maggiolo, F., Mussini, C., Puoti, M., Antinori, C. F. Perno. Steering Committee: A., Bai, F., Bandera, A., Bonora, S., Borderi, M., Calcagno, A., Capobianchi, M. R., Ceccherini-Silberstein, F., Cicalini, S., Cingolani, A., Cinque, P., d’Arminio Monforte, A., Di Biagio, A., Gagliardini, R., Gianotti, N., Guaraldi, G., Lapadula, G., Lichtner, M., Lai, A., Madeddu, G., Marchetti, G., Merlini, E., Nozza, S., Perno, C. F., Piconi, S., Pinnetti, C., Quiros Roldan, E., Rossotti, R., Rusconi, S., Santoro, M. M., Saracino, A., Sarmati, L., Spagnuolo, V., Svicher, V., Taramasso, L., Cozzi-Lepri, Statistical and Monitoring Team: A., Fanti, I., Galli, L., Lorenzini, P., Rodanó, A., Macchia, M., Bove, A. Tavelli. Community Advisory Board: A., Camposeragna, A., Errico, M., Manfredini, M., Perziano, A., Carletti, V. Calvino. Biological Bank INMI: F., Carrara, S., Di Caro, A., Graziano, S., Petroni, F., Prota, G., Giacometti, S. Truffa. Participating Physicians and Centers: Italy: A., Costantini, A., Barocci (Ancona), V., Angarano, G., Monno, L., Milano (Bari), E., F. Maggiolo, C. Suardi (Bergamo), Viale, P., Donati, V., Verucchi (Bologna), G., Castelnuovo, F., Minardi, C., Quiros Roldan (Brescia), E., B. Menzaghi, C. Abeli (Busto Arsizio), L. Chessa, F. Pes (Cagliarti), B. Cacopardo, B. Celesia (Catania), J. Vecchiet, K. Falasca (Chieti), A. Pan, S. Lorenzotti (Cremona), L. Sighinolfi, D. Segala (Ferrara), P. Blanc, F. Vichi (Firenze), Cassola, G., Bassetti, M., Alessandrini, A., Bobbio, N., Mazzarello (Genova), G., M. Lichtner, L. Fondaco (Latina), P. Bonfanti, C. Molteni (Lecco), A. Chiodera, P. Milini (Macerata), G. Nunnari, G. Pellicanò (Messina), Rizzardini, G., Cannizzo, E. S., Moioli, M. C., Piolini, R., Bernacchia, D., Poli, A., Tincati (Milano), C., C. Mussini, C. Puzzolante (Modena), C. Migliorino, G. Lapadula (Monza), Sangiovanni, V., Borgia, G., Esposito, V., Di Flumeri, G., Gentile, I., Rizzo (Napoli), V., A. M. Cattelan, S. Marinello (Padova), A. Cascio, M. Trizzino (Palermo), D. Francisci, E. Schiaroli (Perugia), G. Parruti, F. Sozio (Pescara), C. Lazzaretti, R. Corsini (Reggio Emilia), Cristaudo, A., Vullo, V., Acinapura, R., Lamonica, S., Capozzi, M., Mondi, A., Rivano Capparuccia, M., Iaiani, G., Latini, A., Onnelli, G., Plazzi, M. M., De Girolamo, G., Vergori (Roma), A., M. Cecchetto, F. Viviani (Rovigo), G. Madeddu, A. De Vito (Sassari), B. Rossetti, F. Montagnani (Siena), A. Franco, R. Fontana Del Vecchio (Siracusa), Di Giuli (Terni), C., Caramello, P., Orofino, G. C., Sciandra (Torino), M., Londero (Udine), A., V. Manfrin, G. Battagin (Vicenza), G. Starnini, A. Ialungo (Viterbo)., Malagnino, V, Cerva, C, Cingolani, A, Ceccherini-Silberstein, F, Vergori, A, Cuomo, G, Perno, C, Puoti, M, D'Arminio Monforte, A, Cozzi-Lepri, A, Andreoni, M, Sarmati, L, Malagnino, V., Cerva, C., Cingolani, A., Ceccherini-Silberstein, F., Vergori, A., Cuomo, G., Perno, C. F., Puoti, M., D'Arminio Monforte, A., Cozzi-Lepri, A., Andreoni, M., Sarmati, L., ICONA Foundation Study, Group, Castagna, A., Malagnino V., Cerva C., Cingolani A., Ceccherini-Silberstein F., Vergori A., Cuomo G., Perno C.F., Puoti M., D'Arminio Monforte A., Cozzi-Lepri A., Andreoni M., and Sarmati L.A Castagna, F Castelli, R Cauda, G Di Perri, M Galli, R Iardino, G Ippolito, A Lazzarin, G C Marchetti, G Rezza, F von Schloesser, E Girardi, A Gori, S Lo Caputo, F Maggiolo, F Bai, A Bandera, S Bonora, M Borderi, A Calcagno, M R Capobianchi, S Cicalini, P Cinque, A Di Biagio, R Gagliardini, N Gianotti, G Guaraldi, G Lapadula, M Lichtner, A Lai, S Lo Caputo, G Madeddu, G Marchetti, E Merlini, C Mussini, S Nozza, S Piconi, C Pinnetti, E Quiros Roldan, R Rossotti, S Rusconi, M M Santoro, A Saracino, V Spagnuolo, V Svicher, L Taramasso, I Fanti, L Galli, P Lorenzini, A Rodanó, M Macchia, A Tavelli, A Bove, A Camposeragna, M Errico, M Manfredini, A Perziano, V Calvino, F Carletti, S Carrara, A Di Caro, S Graziano, F Petroni, G Prota, S Truffa, A Giacometti, A Costantini, V Barocci, G Angarano, L Monno, E Milano, C Suardi, V Donati, G Verucchi, F Castelnuovo, C Minardi, B Menzaghi, C Abeli, L Chessa, F Pes, B Cacopardo, B Celesia, J Vecchiet, K Falasca, A Pan, S Lorenzotti, L Sighinolfi, D Segala, P Blanc, F Vichi, G Cassola, M Bassetti, A Alessandrini, N Bobbio, G Mazzarello, M Lichtner, L Fondaco, P Bonfanti, C Molteni, A Chiodera, P Milini, G Nunnari, G Pellicanò, , G Rizzardini, E S Cannizzo, M C Moioli, R Piolini, D Bernacchia, A Poli, C Tincati, C Puzzolante, C Migliorino, G Lapadula, V Sangiovanni, G Borgia, V Esposito, G Di Flumeri, I Gentile, V Rizzo, A M Cattelan, S Marinello, A Cascio, M Trizzino, D Francisci, E Schiaroli, G Parruti, F Sozio, C Lazzaretti, R Corsini, A Antinori, A Cristaudo, V Vullo, R Acinapura, S Lamonica, M Capozzi, A Mondi, M Rivano Capparuccia, G Iaiani, A Latini, G Onnelli, M M Plazzi, G De Girolamo, M Cecchetto, F Viviani, G Madeddu, A De Vito, B Rossetti, F Montagnani, A Franco, R Fontana Del Vecchio, C Di Giuli, P Caramello, G C Orofino, M Sciandra, A Londero, V Manfrin, G Battagin, G Starnini, A Ialungo

Subjects
HBsAg, medicine.medical_specialty, Hepatitis C virus, Liver fibrosis, Human immunodeficiency virus (HIV), OBI, medicine.disease_cause, anti-HBc, HBV, HIV/HBV coinfection, liver fibrosis, Gastroenterology, Major Articles, NO, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Hiv infected patients, 030212 general & internal medicine, Hepatitis B virus, business.industry, liver fibrosi, virus diseases, Settore MED/17, digestive system diseases, Anti-HBc, HIV-HBV coinfection, HBV, Liver fibrosis, OBI, Infectious Diseases, AcademicSubjects/MED00290, HIV-HBV coinfection, Oncology, Cohort, 030211 gastroenterology & hepatology, business, Hepatic fibrosis
Abstract

Background The aim of this study was to investigate the impact of anti-HBc (HBcAb) positivity on the progression of liver fibrosis (Fibrosis-4 score >3.25) in the Italian cohort of HIV-infected individuals naïve to antiretroviral treatment (ICONA). Methods All patients with FIB-4 Results Patients who were HBcAb+/HCV-/HBs antigen (HBsAg)- and HCV+/HBcAb+/HBsAg- or HBsAg+/HBcAb+/HCV- had CD4+ cell counts below the nadir and significantly higher prevalence of AIDS diagnosis at baseline than the other groups (P < .0001). A Cox regression model adjusted for age, HIV transmission mode, country of birth, and alcohol consumption showed a higher relative risk (HR) of progression to FIB-4 >3.25 in HCV+/HBcAb+/HBsAg- patients (HR, 7.2; 95% CI, 3 8–13.64). Conclusions HBcAb+ contributes to liver damage in HIV+/HCV+/HBcAb+/HBsAg- subjects. A careful monitoring for signs of previous HBV infection is needed in this kind of patients.

Published
2021

11. Smoking status during first-line immunotherapy and chemotherapy in NSCLC patients: A case-control matched analysis from a large multicenter study

Author

Cortellini, A, De Giglio, A, Cannita, K, Cortinovis, D, Cornelissen, R, Baldessari, C, Giusti, R, D'Argento, E, Grossi, F, Santoni, M, Catino, A, Berardi, R, Sforza, V, Rossi, G, Antonuzzo, L, Di Noia, V, Signorelli, D, Gelibter, A, Occhipinti, M, Follador, A, Rastelli, F, Chiari, R, Gravara, L, Inno, A, De Tursi, M, Di Marino, P, Mansueto, G, Zoratto, F, Filetti, M, Montrone, M, Citarella, F, Pensieri, M, Russano, M, Cantini, L, Nigro, O, Leonetti, A, Bordi, P, Minuti, G, Landi, L, De Toma, A, Donisi, C, Ricciardi, S, Migliorino, M, Napoli, V, Leone, G, Metro, G, Banna, G, Friedlaender, A, Addeo, A, Ficorella, C, Porzio, G, Cortellini A, De Giglio A, Cannita K, Cortinovis D, Cornelissen R, Baldessari C, Giusti R, D'Argento E, Grossi F, Santoni M, Catino A, Berardi R, Sforza V, Rossi G, Antonuzzo L, Di Noia V, Signorelli D, Gelibter A, Occhipinti MA, Follador A, Rastelli F, Chiari R, Gravara LD, Inno A, De Tursi M, Di Marino P, Mansueto G, Zoratto F, Filetti M, Montrone M, Citarella F, Pensieri MV, Russano M, Cantini L, Nigro O, Leonetti A, Bordi P, Minuti G, Landi L, De Toma A, Donisi C, Ricciardi S, Migliorino MR, Napoli VM, Leone G, Metro G, Banna GL, Friedlaender A, Addeo A, Ficorella C, Porzio G, Cortellini, A, De Giglio, A, Cannita, K, Cortinovis, D, Cornelissen, R, Baldessari, C, Giusti, R, D'Argento, E, Grossi, F, Santoni, M, Catino, A, Berardi, R, Sforza, V, Rossi, G, Antonuzzo, L, Di Noia, V, Signorelli, D, Gelibter, A, Occhipinti, M, Follador, A, Rastelli, F, Chiari, R, Gravara, L, Inno, A, De Tursi, M, Di Marino, P, Mansueto, G, Zoratto, F, Filetti, M, Montrone, M, Citarella, F, Pensieri, M, Russano, M, Cantini, L, Nigro, O, Leonetti, A, Bordi, P, Minuti, G, Landi, L, De Toma, A, Donisi, C, Ricciardi, S, Migliorino, M, Napoli, V, Leone, G, Metro, G, Banna, G, Friedlaender, A, Addeo, A, Ficorella, C, Porzio, G, Cortellini A, De Giglio A, Cannita K, Cortinovis D, Cornelissen R, Baldessari C, Giusti R, D'Argento E, Grossi F, Santoni M, Catino A, Berardi R, Sforza V, Rossi G, Antonuzzo L, Di Noia V, Signorelli D, Gelibter A, Occhipinti MA, Follador A, Rastelli F, Chiari R, Gravara LD, Inno A, De Tursi M, Di Marino P, Mansueto G, Zoratto F, Filetti M, Montrone M, Citarella F, Pensieri MV, Russano M, Cantini L, Nigro O, Leonetti A, Bordi P, Minuti G, Landi L, De Toma A, Donisi C, Ricciardi S, Migliorino MR, Napoli VM, Leone G, Metro G, Banna GL, Friedlaender A, Addeo A, Ficorella C, and Porzio G

Abstract

Background: Improved outcome in tobacco smoking patients with non-small cell lung cancer (NSCLC) following immunotherapy has previously been reported. However, little is known regarding this association during first-line immunotherapy in patients with high PD-L1 expression. In this study we compared clinical outcomes according to the smoking status of two large multicenter cohorts. Methods: We compared clinical outcomes according to the smoking status (never smokers vs. current/former smokers) of two retrospective multicenter cohorts of metastatic NSCLC patients, treated with first-line pembrolizumab and platinum-based chemotherapy. Results: A total of 962 NSCLC patients with PD-L1 expression ≥50% who received first-line pembrolizumab and 462 NSCLC patients who received first-line platinum-based chemotherapy were included in the study. Never smokers were confirmed to have a significantly higher risk of disease progression (hazard ratio [HR] = 1.49 [95% CI: 1.15–1.92], p = 0.0022) and death (HR = 1.38 [95% CI: 1.02–1.87], p = 0.0348) within the pembrolizumab cohort. On the contrary, a nonsignificant trend towards a reduced risk of disease progression (HR = 0.74 [95% CI: 0.52–1.05], p = 0.1003) and death (HR = 0.67 [95% CI: 0.45–1.01], p = 0.0593) were reported for never smokers within the chemotherapy cohort. After a random case–control matching, 424 patients from both cohorts were paired. Within the matched pembrolizumab cohort, never smokers had a significantly shorter progression-free survival (PFS) (HR = 1.68 [95% CI: 1.17–2.40], p = 0.0045) and a nonsignificant trend towards a shortened overall survival (OS) (HR = 1.32 [95% CI: 0.84–2.07], p = 0.2205). On the contrary, never smokers had a significantly longer PFS (HR = 0.68 [95% CI: 0.49–0.95], p = 0.0255) and OS (HR = 0.66 [95% CI: 0.45–0.97], p = 0,0356) compared to current/former smoker patients within the matched chemotherapy cohort. On pooled multivariable analysis, the interaction term between smoking stat

Published
2021

17. Predictors of Zero X-Ray Ablation for Supraventricular Tachycardias in a Nationwide Multicenter Experience

Author

Pani, A, Belotti, G, Bonanno, C, Bongiorni, M, Bottoni, N, Brambilla, R, de Ceglia, S, Della Bella, P, de Vito, G, Malaspina, D, Menardi, E, Napoli, V, Negroni, M, Ocello, S, Orsida, D, Pandozi, C, Pedretti, S, Penela, D, Pepi, P, Rossi, L, Rovaris, G, Scopinaro, A, Vincenti, A, Viola, G, Zacà, V, Zoppo, F, Vergara, P, Bongiorni, MG, Negroni, MS, Pani, A, Belotti, G, Bonanno, C, Bongiorni, M, Bottoni, N, Brambilla, R, de Ceglia, S, Della Bella, P, de Vito, G, Malaspina, D, Menardi, E, Napoli, V, Negroni, M, Ocello, S, Orsida, D, Pandozi, C, Pedretti, S, Penela, D, Pepi, P, Rossi, L, Rovaris, G, Scopinaro, A, Vincenti, A, Viola, G, Zacà, V, Zoppo, F, Vergara, P, Bongiorni, MG, and Negroni, MS

Abstract

BACKGROUND: This multicenter, prospective study evaluated the determinants of zero-fluoroscopy (ZFL) ablation of supraventricular tachycardias.METHODS AND RESULTS: Four hundred thirty patients (215 male, 55.4 +/- 22.1 years) with indication to electrophysiological study or ablation of supraventricular tachycardias were enrolled. All participating physicians agreed to follow the as low as reasonably achievable policy. A procedure was defined as ZFL when no fluoroscopy was used. The total fluoroscopy time inversely correlated to the number of procedures previously performed by each operator since study start (r=-0.112; P=0.02). Two hundred eighty-nine procedures (67.2%) were ZFL; multivariable analysis identified as predictors of ZFL: procedure after the 30th for each operator, compared with procedures up to the ninth (P=0.011; hazard ratio, 3.49; 95% confidence interval [ CI], 1.79-6.80); the type of arrhythmia (P=0.031; electrophysiological study and atrioventricular nodal reentry tachycardia ablation having the highest probability of ZFL; hazard ratio, 6.87; 95% CI, 2.08-22.7 and hazard ratio, 2.02; 95% CI, 1.04-3.91, respectively); the operator's (P=0.002) and patient's age (P=0.009). Among operators, achievement of ZFL varied from 0% to 100%; 8 (22.8%) operators achieved ZFL in <25% of their procedures; 17 (48.6%) operators achieved ZFL in >75% of their procedures. The probability of ZFL increased by 2.8% (hazard ratio, 0.98; 95% CI, 0.97-0.99) as patient's age decreased by 1 year. Acute procedural success was obtained in all cases.CONCLUSIONS: The use of 3-dimensional mapping system completely avoided the use of fluoroscopy in most cases, with very low fluoroscopy time in the remaining and high safety and effectiveness profiles. Achievement of ZFL was predicted by the type of arrhythmia, operator's experience, and patient's age

Published
2018

20. Comparative effects of Folfirinox and Gemcitabine/nab-paclitaxel as first and second line chemotherapy for metastatic pancreatic cancer: single choice or sequence

Author

Caponnetto, S., primary, Gelibter, A., additional, Mosillo, C., additional, Magri, V., additional, Scagnoli, S., additional, Pomati, G., additional, Piesco, G., additional, Verkhovskaya, S., additional, Pisegna, S., additional, Sirgiovanni, G., additional, Napoli, V., additional, Buscicchio, D., additional, Iannantuono, G.M., additional, Marinelli, D., additional, Mammone, G., additional, Pannunzio, S., additional, Nicolo', E., additional, Stefani, A., additional, Astorino, V., additional, Mancini, M., additional, and Cortesi, E., additional

Published
2017
Full Text
View/download PDF

21. P1246Age-, body size-, and sex-specific reference values for tricuspid valve apparatus parameters by real-time three-dimensional transthoracic echocardiographyP1247Surgical therapy in infective endocarditis: predisposing and prognostic factorsP1248Evalutation of MV annulus geometry modifications before and after mitraclip implantation with 3D transesophageal echocardiographyP1249Prognostic echocardiographic parameters for successful transcatheter edge-to-edge mitral valve repairP1250Influence of body surface area in diagnosis and outcome patient-prosthesis mismatch after TAVI. Is it necessary to adjust for ideal body weight?P1251Outcome of paradoxical low-flow low-gradient severe AS following TAVI: paradoxical VS parallel to outcome of high gradient ASP1252Prognostic role of cardiac calcifications in subjects without overt significant heart disease and previous cardiovascular events: is there an additive value over cardiovascular risk factors scores?P1253Aging degeneration of mitral valve without leaflet prolapse or tethering as a cause of severe mitral regurgitationP1254Cardiovascular risk assessment should be performed in patients with incidental aortic sclerosisP1255Cardiac valve calcification score: simple 2D echocardiographic tool for cardiovascular risk stratification in patients with chronic renal failureP1256Diastolic mitral regurgitation following transcatheter aortic valve replacement: prevalence, predictors and impact on outcomesP1257Timing of myocardial shortening determines left ventricular regional remodelling in hearts with conduction delaysP1258Myocardial stiffness assessment using shear wave imaging in healthy children and hypertrophic cardiomyopathyP1259Assessment of right ventricular response to exercise using vector velocity imaging in hypertrophic cardiomyopathyP1260Diagnostic value of cardiac biomarkers (high sensitive troponin T and N-terminal pro-brain natriuretic peptide) in patients with infiltrative cardiomyopathiesP1261Right ventricular global longitudinal strain differentiates between adolescent patients with definite, borderline and possible ARVC and controlsP1262 echogrqphic predictif factors of atrial arrhythmias in patients with arrhythmogenic right ventricular dysplasiaP1263Importance of combined left atrial size and estimated pulmonary pressure for clinical outcome in patients presenting with heart failure with preserved ejection fractionP1264Chronotropic response in mitochondrial (ANT1) cardiomyopathyP1265 The effect of cardiovascular risk factors and cancer type in anthracycline's cardiotoxicityP1266Revisiting the echocardiographic features of acute myocarditisP1267Altered circulation in fetuses of diabetic mothers: a fetal computational model analysisP1268Increased epicardial adipose tissue is related to stress-induced cardiomyopathyP1269Contrast enhanced ultrasound of kidney perfusion in patients with renal artery stenosis: diagnostic and prognostic applications.

Author

Ancona, F., primary, Ilhao Moreira, R., primary, Lavanco, V., primary, Lesevic, H., primary, Islas, FI., primary, Katbeh, A., primary, Mazzone, C., primary, Isotani, A., primary, Arnold, LJ., primary, Papadopoulos, C., primary, Flint, N., primary, Cvijic, M., primary, Villemain, O., primary, Hamed, W., primary, Hu, K., primary, Pieles, GE., primary, Zaroui, A., primary, Donal, E., primary, Chowdhury, D., primary, Gomes, AC., primary, Pena-Pena, ML., primary, Kulkarni, A., primary, Park, SM., primary, Castellani, S., primary, Marini, C., additional, Stella, S., additional, Rosa, I., additional, Margonato, A., additional, Agricola, E., additional, Coutinho Cruz, M., additional, Moura Branco, L., additional, Galrinho, A., additional, Coutinho Miranda, L., additional, Timoteo, AT., additional, Viveiros Monteiro, A., additional, Portugal, G., additional, Fragata, J., additional, Cruz Ferreira, R., additional, Leo, LA., additional, Pasotti, E., additional, Faletra, FF., additional, Moccetti, T., additional, Karl, M., additional, Rosner, S., additional, Ott, I., additional, Sonne, C., additional, Olmos, C., additional, De Agustin, A., additional, Almeria, C., additional, Marcos-Alberca, P., additional, Nombela, L., additional, Mahia, P., additional, Rodrigo, JL., additional, Luaces, M., additional, Jimenez, P., additional, Parra, B., additional, Gomez, JJ., additional, Garcia Fernandez, MA., additional, Macaya, C., additional, Perez De Isla, L., additional, Islas, F., additional, Fernandez Ortiz, A., additional, Marcos Alberca, P., additional, Luis Rodrigo, J., additional, Gomez De Diego, J., additional, Di Nora, C., additional, Guidetti, F., additional, Barbati, G., additional, Faggiano, P., additional, Gaibazzi, N., additional, Di Lenarda, A., additional, Cherubini, A., additional, Faganello, G., additional, Cioffi, G., additional, Schau, T., additional, Neuss, M., additional, Schoepp, M., additional, Butter, C., additional, Coffey, S., additional, Loudon, M., additional, Wilson, J., additional, Kennedy, A., additional, Myerson, S., additional, Prendergast, B., additional, Mpaltoumas, K., additional, Triantafyllou, K., additional, Fotoglidis, A., additional, Kassimatis, E., additional, Sampani, E., additional, Pagourelias, E., additional, Papagianni, A., additional, Kotsiouros, G., additional, Vassilikos, V., additional, Rozenbaum, Z., additional, Topilsky, Y., additional, Biner, S., additional, Finkelstein, A., additional, Banai, S., additional, Keren, G., additional, Halkin, A., additional, Michalski, B., additional, Stankovic, I., additional, Duchenne, J., additional, Voigt, JU., additional, Correia, M., additional, Khraiche, D., additional, Pernot, M., additional, Bonnet, D., additional, Badran, HMB, additional, Ahmed, NFA, additional, Liu, D., additional, Nordbeck, P., additional, Herrmann, S., additional, Ertl, G., additional, Weidemann, F., additional, Stoerk, S., additional, Hader, M., additional, Fatah, M., additional, Chungsomprasong, P., additional, Slorach, C., additional, Mertens, L., additional, Grosse-Wortmann, L., additional, Hamilton, R., additional, Friedberg, MK., additional, Drissi, MF., additional, Ben Said, R., additional, Mechmeche, R., additional, Lund, LH., additional, Oger, E., additional, Hage, C., additional, Drouet, E., additional, Daubert, JC., additional, Linde, C., additional, Pascua, C., additional, Strauss, K., additional, Puffenberger, E., additional, Bijnens, B., additional, Lopes, LR., additional, Ferreira, AG., additional, Mansinho, H., additional, Pereira, H., additional, Maglione, F., additional, Rangel-Sousa, D., additional, Sobrino-Marquez, JM., additional, Lage-Galle, E., additional, Martinez-Martinez, A., additional, Lopez-Pardo, F., additional, Lopez Haldon, JE., additional, Urbano-Moral, JA., additional, Garcia Canadilla, P., additional, Khan, A., additional, Beckerman, K., additional, Crispi, F., additional, Cruz-Lemini, M., additional, Valenzuela Alcaraz, B., additional, Gomez, O., additional, Gratacos, E., additional, Kim, MN., additional, Shim, WJ., additional, Castellini, G., additional, Brkljacic, B., additional, Drudi, F., additional, Bertolotto, M., additional, Cruz, BK., additional, Needleman, L., additional, Napoli, V., additional, Modesti, PA., additional, and Marchionni, N., additional

Published
2016
Full Text
View/download PDF

33. Sclerosi multipla ed insufficienza venosa: niente nuove

Author

Pecori, Chiara, Chiti, Alberto, GIOVANNI ORLANDI, Iudice, A., FERDINANDO SARTUCCI, Benassi, Federico, Del Corso, A., MAURO FERRARI, Napoli, V., Cioni, R., Bartolozzi, C., Maria Chiara Carboncini, BRUNO ROSSI, Giannini, D., and Balbarini, A.

Published
2013

41. Questioning the ‘exotic’ in two Italian travellers’ accounts of New Zealand

Author

Napoli, V

Abstract

L’articolo studia le testimonianze di due missionari italiani presenti in Nuova Zelanda tra la fine dell’Ottocento e l’inizio del Novecento: il benedettino Dom Felice Vaggioli e il salesiano Giuseppe Capra. Sia l’uno sia l’altro, attratti dalle bellezze naturali del paese descritto come una sorta di esotico nuovo Eden, finirono col guardare alla Nuova Zelanda da una prospettiva fortemente eurocentrica, Vaggioli addirittura definendo la Nuova Zelanda – a partire da superficiali coincidenze topografiche – come l’Italia dell’emisfero australe. Di là dalle finalità di proselitismo religioso (permeato da una forte vena antiinglese), gli scritti dei due religiosi costituiscono una viva autorappresentazione dell’Italia e degli italiani mezzo secolo dopo l’unificazione.Article is in English

Published
2012

46. D27 - Comparative effects of Folfirinox and Gemcitabine/nab-paclitaxel as first and second line chemotherapy for metastatic pancreatic cancer: single choice or sequence

Author

Caponnetto, S., Gelibter, A., Mosillo, C., Magri, V., Scagnoli, S., Pomati, G., Piesco, G., Verkhovskaya, S., Pisegna, S., Sirgiovanni, G., Napoli, V., Buscicchio, D., Iannantuono, G.M., Marinelli, D., Mammone, G., Pannunzio, S., Nicolo', E., Stefani, A., Astorino, V., Mancini, M., and Cortesi, E.

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results